Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 61Stomach Neoplasms 10HER2-positive Breast Cancer 7Colorectal Neoplasms 6Neoplasm Metastasis 5Inflammatory Breast Neoplasms 3Breast Diseases 3Brain Neoplasms 3Pathologic Complete Response 2Neoplasms 2Esophageal Squamous Cell Carcinoma 2Cardiotoxicity 2Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor, Adult 1Relapsed Pediatric Solid Tumor 1Pancreatic Neoplasms 1Neoadjuvant Treatment for HER2-positive, ER-positive Breast Cancer 1Invasive Breast Cancer 1Intestinal Neoplasms 1HER2-positive Metastatic Breast Cancer 1HER2-positive Gastric Cancer 1HER2-positive 1HER2+ Early or Locally Advanced Breast Cancer 1HER2+ Breast Cancer 1HER2 Positive Breast Cancer 1HER-2 Positive Gastric Cancer 1Gastrointestinal Neoplasms 1Gallbladder Neoplasms 1Feasibility 1

Interventions

Folfox protocol 3Drug Therapy 3Cisplatin 3apatinib 2anlotinib 2Paclitaxel 2Oxaliplatin 2Fluorouracil 2Capecitabine 2sintilimab 1pyrotinib 1pemigatinib 1huachansu 1donafenib 1Trastuzumab 1Sorafenib 1Radiotherapy 1Physical Conditioning, Human 1Microspheres 1Leucovorin 1Immune Checkpoint Inhibitors 1Docetaxel 1Chemoradiotherapy 1Bevacizumab 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Digestive System Neoplasms × Trastuzumab × Clear all
NCT04960943 2021-07-14

Efficacy and Safety of Pyrotinib in HER2 Positive Gastrointestinal Tumors

Fudan University

Phase 2 Unknown
60 enrolled
Gastrointestinal

Digestive System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡